Trevi Therapeutics (TRVI) EPS (Basic) (2018 - 2026)
Trevi Therapeutics (TRVI) posted quarterly EPS (Basic) of -$0.09 for Q1 2026, down 3.06% year-over-year from -$0.09 in Q1 2025, and down 46.91% quarter-over-quarter from -$0.06 in Q4 2025.
Trevi Therapeutics (TRVI) EPS (Basic) (2018 - 2026) Analysis & Trends
Trevi Therapeutics' EPS (Basic) history runs 9 years deep, the most recent figure standing at -$0.09 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 3.06% year-over-year to -$0.09; the TTM figure through Mar 2026 stood at -$0.31 (up 22.11% YoY), while the FY2025 annual figure was -$0.32, up 32.4% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.09, down from -$0.06 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.06 in Q4 2025, with the low at -$0.24 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.09 (2026), against an average of -$0.1.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) jumped 77.13% in 2022, then tumbled 68.87% in 2024.
- Trevi Therapeutics' EPS (Basic) stood at -$0.09 in 2022, then advanced by 7.41% to -$0.08 in 2023, then tumbled by 41.1% to -$0.11 in 2024, then surged by 44.65% to -$0.06 in 2025, then sank by 46.91% to -$0.09 in 2026.
- Business Quant data shows TRVI's EPS (Basic) at -$0.09 in Q1 2026, -$0.06 in Q4 2025, and -$0.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.09 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.13 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.08 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | -0.37 |
| Sep 30, 2021 | -0.34 |